31 January 2017 - Deborah Wilkes
Archived
Pfizer said worldwide sales at its Consumer Healthcare business had increased by 4% on an operational basis to USD950 million in the fourth quarter of 2016. The rise for the full year was 5% to USD3.41 billion.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.